Indian regulatory reform is welcome, but "more work needs to be done"
This article was originally published in Clinica
Executive Summary
The nine-point revision of India's medical device regulations - "clarifications on guidelines for import and manufacture of medical devices" - issued recently by the Central Drugs Standard Control Organization (CDSCO) - has been broadly welcomed by industry.